Skip to content

A Comparison of PanOptix and ReSTOR+3.0D on intermediate vision in cataract patients: a prospective, multi-center study

A Comparison of PanOptix and ReSTOR+3.0D on intermediate vision in cataract patients: a prospective, multi-center study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043729
Enrollment
Unknown
Registered
2021-02-27
Start date
2021-02-23
Completion date
Unknown
Last updated
2021-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cataract

Interventions

PanOptix group:PanOptix intraocular lens implantation in both eyes
ReSTOR+3.0D:ReSTOR+3.0D

Sponsors

Shenyang Aier Excellence Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Subjects with clear cognitive ability; 2. For those patients with cataract and presbyopia, corneal astigmatism 2.5mm, dark vision < 6.0mm; Kappa angle < 0.5 mm; 5. According to emery little grading system, the patients with binocular nuclear hardness grade I-IV had a smooth operation without complications, such as posterior capsule rupture.

Exclusion criteria

Exclusion criteria: 1. Subjects with history of internal eye surgery and ocular trauma. 2. Patients with keratopathy, glaucoma and chronic recurrent uveitis. 3. Diabetic retinopathy, age-related macular degeneration, occult macular degeneration, optic neuropathy. 4. Subjects with obvious ametropia, such as myopia greater than - 6.0d, hyperopia greater than + 5.0d; Corneal astigmatism > 0.75D. 5. In the subjects with loose ciliary body suspensory ligament and capsulorhexis radius greater than 5.5mm, the capsular bag was broken, the intraocular lens was not in the center, the posterior capsular incision was performed in the patients with posterior cataract and other ocular complications.

Design outcomes

Primary

MeasureTime frame
Vision and optometry intraocular pressure;Defocus curve;Wavefront aberration and MTF curve;

Countries

China

Contacts

Public ContactZhang Jinsong

Shenyang Aier Excellence Eye Hospital

cmu4h-zjs@126.com+86 13066667486

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026